Quantus

SEC FORM 13F

안드레아스 할보르센

Viking Global Investors

Andreas Halvorsen

공시 기준일
2026-03-31
표시 종목
40 / 77
13F 평가액
$35.7B

이번 분기 하이라이트 (2026-03-31 공시)

신규 매수11

Apple, Fedex, Meta Platforms Class A …

추가 매수12

Visa Class A, Fortive, Tesla …

축소12

Sherwin Williams, BridgeBio Pharma, Microsoft …

보유 종목

비중 높은 순

  1. 1
    Visa Class A9.6%
    V-US · $1.9B추가+2,343,980주
  2. 2
    Fortive6.3%
    FTV-US · $1.2B추가+3,251,123주
  3. 3
    Sherwin Williams5%
    SHW-US · $997.8M축소-59,541주
  4. 4
    Tesla4.7%
    TSLA-US · $927M추가+793,820주
  5. 5
    Apple4.6%
    AAPL-US · $911.9M신규
  6. 6
    BridgeBio Pharma4.4%
    BBIO-US · $879.4M축소-2,551,500주
  7. 7
    Carvana Class A4.4%
    CVNA-US · $874M추가+1,718,502주
  8. 8
    Microsoft4.3%
    MSFT-US · $854.9M축소-908,196주
  9. 9
    Thermo Fisher Scientific4.1%
    TMO-US · $819.9M추가+874,838주
  10. 10
    JPMorgan Chase4%
    JPM-US · $795.4M추가+798,036주
  11. 11
    CSX3.9%
    CSX-US · $766.7M추가+4,860,513주
  12. 12
    Alphabet Class A3.5%
    GOOGL-US · $689M축소-270,407주
  13. 13
    Fedex3.5%
    FDX-US · $688.2M신규
  14. 14
    Boeing3.2%
    BA-US · $636.1M축소-757,046주
  15. 15
    T Mobile US3.1%
    TMUS-US · $623.2M축소-786,844주
  16. 16
    Meta Platforms Class A3.1%
    META-US · $607.9M신규
  17. 17
    Regal Rexnord3%
    RRX-US · $588.5M축소-81,089주
  18. 18
    HCA Healthcare2.6%
    HCA-US · $508.8M추가+75,953주
  19. 19
    ATI2.4%
    ATI-US · $484.8M신규
  20. 20
    Celestica2.3%
    CLS-US · $466.2M축소-44,247주
  21. 21
    BioMarin Pharmaceutical2%
    BMRN-US · $398.9M추가+1,025,141주
  22. 22
    Waters1.9%
    WAT-US · $374.2M신규
  23. 23
    Carnival1.8%
    CCL-US · $355.1M축소-340,479주
  24. 24
    Aon Class A1.8%
    AON-US · $350.9M추가+303,464주
  25. 25
    Hasbro1.8%
    HAS-US · $350M신규
  26. 26
    Progressive1.6%
    PGR-US · $320.5M추가+285,021주
  27. 27
    Amazon Com1.3%
    AMZN-US · $249M축소-1,931,388주
  28. 28
    APi Group1.2%
    APG-US · $236.5M축소-5,700,518주
  29. 29
    Roivant Sciences0.9%
    ROIV-US · $184.3M추가+209,257주
  30. 30
    Home Depot0.8%
    HD-US · $165.8M신규
  31. 31
    lululemon athletica0.8%
    LULU-US · $150.1M신규
  32. 32
    Pharvaris N V0.5%
    PHVS-US · $103.2M유지
  33. 33
    Edwards Lifesciences0.4%
    EW-US · $87.9M신규
  34. 34
    ORIC Pharmaceuticals0.4%
    ORIC-US · $73.8M축소-748,158주
  35. 35
    Twilio Class A0.3%
    TWLO-US · $56.7M신규
  36. 36
    Standard BioTools0.3%
    LAB-US · $53.9M유지
  37. 37
    Trevi Therapeutics0.2%
    TRVI-US · $38.2M유지
  38. 38
    Ginkgo Bioworks Holdings Class A0.1%
    DNA-US · $21.9M유지
  39. 39
    PepGen0%
    PEPG-US · $6.2M유지
  40. 40
    Rallybio0%
    RLYB-US · $4.7M신규

사실 정보이며 투자 조언이 아닙니다.